ASAP Advisory Council
Shaping ASAP’s priorities, programs, and future.
The ASAP Advisory Council reports to the Board of Directors and provides strategic guidance and recommendations in support of ASAP’s mission.
The Council meets quarterly (two meetings virtual; two in person at the ASAP Summit and BioPharma Conference) and is chaired by the Vice Chair of the Board. Members serve renewable two-year terms beginning July 1 and are selected based on their active engagement and contributions to the association.
Chris Black, CA-AM
Head, Corporate Alliance Management & Integration
Merck
Suzanne Collins
Head, Strategy & Operations R&D Strategy & External Innovation
Takeda
Annick De Swaef, CSAP, CA-AM
Transition Executive
Yocoto BV
Katherine Ellison, CA-AM
Senior Director, Head of Alliance Management
Illumina
Michelle Gardner, CA-AM
Director of Industry Partnerships and Engagement
Northeastern University
Tomoko Hanadate
Head of RD Alliances, Business Development
Astellas Pharma
Brent Harvey, CA-AM
Executive Director, Alliance Management
Eli Lilly and Company
Christoph Huwe, PhD, CSAP, CA-AM
Senior Director, Strategic Alliance Management
Bayer AG Pharmaceuticals
Adam Kornetsky
Partner
Vantage Partners
Kevin Little, PhD, CSAP, CA-AM
Senior Director, Alliances
Novo Nordisk
Robert Porter Lynch, CA-AM
President
The Warren Company
Nancy Ridge, CA-AM
Founder & President
Ridge Innovative
Louis Rinfret
Founder & CEO
allianceboard
Phil Sack, CSAP, CA-AM, MICW
Managing Director
CollaboRare
Philip Sailer, CSAP, CA-AM
Executive Director, Storage Solutions Team
IBM
Stefanie Schubert, PhD, CSAP, CA-AM
Director, Int'l Business Program
SRH Hochschule Heidelberg
Bill Thomas, CA-AM
Director, SI Alliances
PTC
Stefan Walke, PhD, CA-AM
Global Head of Alliance Management
Boehringer Ingelheim
Cindy Warren
Chief Business Officer
Cue Biopharma
Norma Watenpaugh, CSAP, CA-AM
CEO & Founding Principal
Phoenix Consulting Group
Arne Wörn, PhD
Global Head Alliance Management
Novartis Pharmaceuticals